Pressemitteilungen zu dem Thema pharmaceutical


Unterkategorien

PresseMitteilungen zu dem Schlagwort pharmaceutical


PAREXEL Appoints Jamie Macdonald as Chief Executive Officer

BOSTON, March 6, 2018 - PAREXEL International Corporation, the world''s leading innovator of biopharmaceutical services, today announced the appointment of Jamie Macdonald as Chief Executive Officer (CEO) effective March 15, 2018. Josef von Rickenbach, who co-founded the Company, will retire from his daily CEO duties and continue as Chairman of the Board. "It is a tremendous honor for me to join PAREXEL," said Jamie Macdonald. "As a trail blazer in the biopharmaceutic ...


06.03.2018

Alfa Laval´s UltraPure Pumps - Efficient, Sustainable and Consumer Safe

Alfa Laval UltraPure pumps are specifically designed for the toughest, most demanding pharmaceutical applications. From high-value, high-risk productions, where every second counts, to reliability and repeatability process-driven productions - whatever your challenge is, there is an UltraPure solution to meet your needs. Consumer Safety Alfa Laval UltraPure pumps feature a high level of attention to hygiene and repeatability to reduce the risk of contamination. The downloadable Q-doc documenta ...


21.02.2018

PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development

BOSTON, February 12, 2018 - PAREXEL International Corporation, the world''s leading innovator of biopharmaceutical services, today launched its Biological Sample Lifecycle Management service, enabling optimal use of human biological samples. The new service enables biopharmaceutical clients to more efficiently manage their often irreplaceable patient biological sample assets from informed consent and collection at site, through in-study laboratory analysis, data generation and future u ...


12.02.2018

NEW! LogTag® USB Data Logger Series!

The growing LogTag effective and reliable models with integrated USB port. The two LogTag They are complemented by the reusable USB loggers UTRIX-16 and UTRID-16. These two data loggers are ideal for all applications where a logger can easily be recovered and reused several times. All USB models can be plugged directly into a PC In addition, the UTRID-16 also impresses with its six level multi-alarm display. LogTag data loggers are praised worldwide for their reliability and ease of use, exce ...


30.01.2018

Worldwide Pharmaceutical Packaging Market Share, Size, Growth, Trends, Industry Analysis and Forecast 2025 By Credence Research

According to the latest report published by Credence Research, Inc. Browse the full Market Insights Global pharmaceutical packaging market comprises study of all the materials used for packaging of the pharmaceuticals. The global market includes the packaging carried out by the manufacturing companies as well as drugs packed on the contract basis. Numerous materials are utilized for the packaging of the drugs including plastics, polymers, paper, glass, aluminum foil. Due to the increasing glo ...


19.12.2017

Pivot Pharma Licenses Thrudermic Transdermal Nanotechnology and Expands Scientific Advisory Board

VANCOUVER, BC -- (Marketwired) -- 11/09/17 -- . (OTCQB: PVOTF) ("Pivot" or the "Company") is pleased to announce the signing of a Binding Letter of Intent with Thrudermic, LLC, a privately held North Carolina company, to acquire worldwide rights to Thrudermic''s Transdermal Nanotechnology for the development and commercialization of topical cannabinoids. In addition, Dr. Joseph Borovsky and Dr. Leonid Lurya, Thrudermic''s Chief Executive Officer and Chief ...


09.11.2017

Pharmaceutical Companies Poised to Build Infrastructure to Accommodate Real World Evidence, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 11/08/17 -- Real world evidence is poised to play a growing role in drug development during the next three years, but the availability and cost of acquiring data remain key challenges, according to a recently completed study conducted by the .Large pharmaceutical, biotechnology, and contract research organizations plan to increase internal staff dedicated to collection and analysis of real world data by 25% between now and 2020, according to a survey conducted by ...


08.11.2017

Vitality Biopharma Completes Pivotal GMP Manufacturing Agreements for Cannabinoid Pharmaceuticals

LOS ANGELES, CA -- (Marketwired) -- 11/01/17 -- (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders, today announced completion of pivotal manufacturing agreements that enable the production of clinical-grade cannabinoid pharmaceuticals at its R&D facili ...


01.11.2017

Pre-Filled Syringes Europe Attendee List Released

Preliminary attendee list released featuring MHRA, Boehringer Ingelheim, Janssen, Amgen, Merck and Novartis, 3P Innovation, Intertek, Nemera, Terumo, Worrell and Zeon (LONDON, UK) SMi’s Pre-Filled Syringes Europe Conference & Exhibition will take place on 17-18 January at the Copthorne Tara Hotel in London, UK. SMi’s 2017 global portfolio of events on Pre-Filled Syringes secured an audience of over 300 senior drug delivery and medical device experts. Growing year on year, the flagship 10 ...


01.11.2017

Sermonix Pharmaceuticals Announces Recent Closure of $4.2 Million Seed Preferred Equity Bridge to Fund Operations, Prepare for Phase II Breast Cancer Study

COLUMBUS, OH -- (Marketwired) -- 10/31/17 -- Sermonix Pharmaceuticals LLC, a privately held biotechnology company focused on the development and commercialization of female-specific oncology products, today announced its recent completion of a $4.2 million Seed Preferred Equity Bridge financing round to fund ongoing operations and prepare for entry of investigational drug lasofoxifene into a Phase II clinical trial in Estrogen Receptor Positive (ER+) Metastatic Breast Cancer.Lasofoxifene, a new ...


31.10.2017

Hemogenyx Pharmaceuticals Plc ("Hemogenyx" or the "Company"): LakePharma appointed as Service Provider for lead drug development

LONDON, UNITED KINGDOM -- (Marketwired) -- 10/30/17 -- Hemogenyx Pharmaceuticals Plc (LSE: HEMO), the biotechnology company developing novel therapies to transform bone marrow, or blood stem cell, transplantation for the treatment of blood diseases, announced today it has chosen LakePharma, Inc. as its service provider for the development and manufacturing of Hemogenyx''s lead product, CDX bi-specific antibodies. The company believes that CDX bi-specific antibodies could replace tradi ...


30.10.2017

Easton Pharmaceuticals Announces Final Payment Completing $1.3 Million JV Agreement With Alliance Group For a 50% Property Ownership Interest and Various Businesses Including The Cultivation of Medical / Recreational Marijuana For National Canadian Market

TORONTO, ON -- (Marketwired) -- 10/20/17 -- Easton Pharmaceuticals, Inc. (OTC: EAPH) is pleased to announce its final payment which completes its $1.3 Million CDN JV agreement with Canadian based 1124123 Ontario Limited (o/a - Alliance Group) towards a 50% property ownership interest and various businesses including the cultivation of medical / recreational marijuana for national Canadian market.Easton has advanced its final payment, completing a total payment of $1.3 Million CDN to 1124123 Ont ...


20.10.2017

Pivot Pharma Executes Binding Letter of Intent to Acquire ACI Foods Inc.

VANCOUVER, BC -- (Marketwired) -- 10/19/17 -- . (OTCQB: PVOTF) ("Pivot" or the "Company"), an emerging biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals, today announces the execution of a Binding Letter of Intent to acquire Absorbent Concepts Inc. ("ACI Foods" or "ACI"). Based in Abbotsford, British Columbia, ACI processes, packages and distributes gluten-free, organic hemp nutrit ...


19.10.2017

Easton Pharmaceuticals & JV Partner Alliance Group Announces It Has Cleared Final Hurdles Toward Allowing For The Cultivation of Medical / Recreational Marijuana For National Canadian Market

TORONTO, ON -- (Marketwired) -- 10/10/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), is pleased to announce, pursuant to its previously announced closed agreement with Canadian based -- 1124123 Ontario Limited (o/a - Alliance Group) -- that its legal team has notified Easton / Alliance Group that it has cleared all exemption hurdles allowing for the Cultivation of Medical / Recreational Marijuana for the country of Canada.Easton''s JV partner, 1124123 Ontario Limited (o/a - Alli ...


10.10.2017

Rising Biosciences, Inc. Launches TSW! Topicals (This (Bleep) Works!), Delivering Innovative Pain Relief to Market in Q4; Unveils Scar Peptide Serum

NEW YORK, NY -- (Marketwired) -- 09/29/17 -- Rising India''s (OTC: RSII) ., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, announces today that it has launched TSW Topicals (), a range of over-the-counter, topical pain relief products using an innovative blend of clinically proven organic ingredients such as menthol, curcumin, ginger and capsaicin to reduce inflammation and e ...


29.09.2017

Canopy Growth and Skinvisible Sign Definitive Agreement to Bring New Products to Market

SMITH FALLS, ON and LAS VEGAS, NV -- (Marketwired) -- 09/28/17 -- Canopy Growth Corporation ("Canopy Growth" or the "Company") and Skinvisible Pharmaceuticals, Inc. ("Skinvisible") (OTCQB: SKVI), a research and development company with a patented drug delivery system, today announce they have signed a definitive license agreement for Skinvisible''s patented topical formulations. Per the agreement, Canopy Growth is exclusively licensed to distribute Skinvi ...


28.09.2017

Pivot Pharma and Solmic Research GmbH Sign License and Collaboration Agreement for Improved Oral Formulations of Cannabinoids

VANCOUVER, BC -- (Marketwired) -- 09/25/17 -- . (OTCQB: PVOTF) (Pivot or the Company) and its medical cannabis product division, Pivot Green Stream Health Solutions, today announce the signing of a Definitive Agreement with Solmic Research GmbH (Germany) in which Pivot will acquire worldwide rights to Solmic Solubilisation Technology for the development and commercialization of cannabinoid-containing natural extracts. Solmic''s proprietary technology provides significantly higher bioa ...


25.09.2017

Cardiovascular Drug Approval Rate in the U.S. Fell as Development Time Rose, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 09/12/17 -- Although the rate at which investigational drugs received marketing approval in the United States has declined in recent years, the cardiovascular approval rate trailed other drug approvals as a whole, while the time needed to develop cardiovascular drugs rose, according to a recently completed study conducted by the .Approval success rates for cardiovascular compounds fell from about 5.2% for compounds that began clinical testing during 1995-00, to ab ...


12.09.2017

Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean

TORONTO, ON -- (Marketwired) -- 09/12/17 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) and its JV partner BMV Medica SA de CV announces that its distributor Windsor Pharmaceuticals SA has received regulatory approval for two of its exclusively licensed Women''s Health Care products for Central America and the Caribbean.After filing the regulatory documents subsequent to a signed sub-licensing agreement with Panama-based Windsor Pharmaceuticals, Easton and BMV Medica have received co ...


12.09.2017

RespireRx Pharmaceuticals Inc. to Present at 2017 Rodman & Renshaw Conference

GLEN ROCK, NJ -- (Marketwired) -- 09/08/17 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for the treatment of respiratory disorders, including sleep apnea, opioid-induced respiratory depression, and respiratory insufficiency due to spinal cord injury, announces that the Company''s Chief Executive Officer and Vice Chairman of the Board of Directors, James S. Manuso, Ph.D., will present at the ...


08.09.2017

Circassia Announces Duaklir(R) Successfully Met Primary Endpoints in AMPLIFY Phase III Study in Chronic Obstructive Pulmonary Disease

OXFORD, UNITED KINGDOM -- (Marketwired) -- 09/07/17 -- Circassia Pharmaceuticals Plc (LSE: CIR)(LSE: CIR)Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty pharmaceutical company focused on respiratory disease, today announces positive top-line results from the AMPLIFY phase III study of Duaklir®* in chronic obstructive pulmonary disease (COPD), which was conducted by the Company''s partner AstraZeneca. Duaklir® is a fixed-dose comb ...


07.09.2017

PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments

Integrated offering to be provided by new dedicated service group under PAREXEL® Access BOSTON, September 6, 2017 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has launched a new end-to-end service offering to provide real-world data insights that help life science companies more effectively demonstrate product value. “In an increasingly competitive market, leveraging data to demonstrate value is critical. How ...


06.09.2017

Easton Pharmaceuticals Announces $1,000,000 cdn In Payments Toward Alliance Group JV / Partnership Agreement; Announces $8,000,000 cdn Aggregate LOI Contract

TORONTO, ON -- (Marketwired) -- 09/05/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), is pleased to announce, pursuant to its previously announced Closing Agreement with Canadian based 124123 Ontario Inc. (O/A - Alliance Group), Easton has advanced $1,000,000 cdn in payments to Alliance Group. Alliance executes $8,000,000 cdn aggregate LOI contract on its 90 acres of zoned industrial land.Easton Pharmaceuticals has thus far paid $1,000,000 cdn in cash out of $1.3 million cdn to Toronto bas ...


05.09.2017

RespireRx Pharmaceuticals Inc. Files June 30, 2017 Quarterly Report on Form 10-Q And Provides Update

GLEN ROCK, NJ -- (Marketwired) -- 08/25/17 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for the treatment of neurologically controlled respiratory disorders, including obstructive sleep apnea and opioid induced respiratory depression (a form of central apnea) and other respiratory and neurological conditions, has filed its June 30, 2017 Quarterly Report on Form 10-Q and is hereby providing an update ...


25.08.2017

Easton Pharmaceuticals and Alliance Group Announces the Closing Of Its First Aggregate Contract Valued At $6,000,000 CDN On Its 90 Acre Portion Of Industrial Zoned Land

TORONTO, ON -- (Marketwired) -- 08/23/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), is pleased to announce, pursuant to its previously announced Closing with Canadian based, joint venture partner, 1124123 Ontario Limited (dba / operating as - Alliance Group) -- executes $6,000,000 CDN aggregate contract on its 90 acres of industrial zoned land.The contract Alliance Group has executed is for its Aggregate business on its 90 acres of industrial zoned land, which includes recycling, manufac ...


23.08.2017

Easton Pharmaceuticals Announces Advancing $575,000 Payment Towards Closed Agreement With Alliance Group For The Cultivation Of Medical / Recreational Marijuana For Canada and Other Revenue Producing Businesses

TORONTO, ON -- (Marketwired) -- 08/16/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), pursuant to its previously announced closing agreement with Canadian based -- Alliance Group -- Easton has advanced $575,000 towards its acquired interest in 45 acres of a 135-acre fully owned parcel of land for the cultivation, production and sale of medical / recreational marijuana to the cannabis industry and towards other revenue producing businesses.Pursuant to the agreement, Easton Pharmaceuticals h ...


16.08.2017

Cocrystal Announces Positive Data from the Successful Completion of Phase 1a/1b Trial of the Non-Nucleoside Polymerase Inhibitor CC-31244 for the Treatment of Chronic Hepatitis C Infection

ATLANTA, GA and BOTHELL, WA -- (Marketwired) -- 08/15/17 -- Cocrystal Pharma, Inc. (OTCQB: COCP), a clinical stage biopharmaceutical company focused on developing innovative antiviral therapeutics, today announced the successful completion and positive data from the Phase 1a/1b study for its lead broad spectrum compound, CC-31244, in healthy volunteers and in hepatitis C virus (HCV)-infected individuals. CC-31244 is a broad-spectrum, potent NS5B non-nucleoside inhibitor (NNI) of HCV replication ...


15.08.2017

Fennec Provides Corporate Update and Announces Second Quarter 2017 Results

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 08/11/17 -- Fennec Pharmaceuticals Inc. (TSX: FRX) (OTCQB: FENCF), a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced ototoxicity in pediatric patients, today reported its corporate update and financial results for the second quarter ended June 30, 2017."As we look forward to the second half of 2017, the pending SIOPEL 6 results have the potential to mar ...


11.08.2017

Easton Pharmaceuticals Announces Finalized Sub-Distribution Agreement With Gedeon Richter S.A.P.I de C.V. For Product Launch Of AmnioSense (AL-Sense)

TORONTO, ON -- (Marketwired) -- 08/10/17 -- Easton Pharmaceuticals Inc. (OTC: EAPH) Announces execution and closing of sub-distribution agreement with Gedeon Richter Plc and its Mexican subsidiary company Gedeon Richter S.A.P.I de C.V. for the product "AmnioSense."The "AmnioSense" distribution agreement represents the second product launch with Gedeon Richter S.A.P.I. de CV following the successful launch of "Gynofit" in the second quarter of this year. An initial ...


10.08.2017

AssistRx Appoints Executive Vice President of Commerical Operations

ORLANDO, FL -- (Marketwired) -- 08/08/17 -- (ARx), the leading enterprise software platform focused on specialty and highly managed medications, today named Jason Reynolds as its executive vice president of commercial operations. In this role, Reynolds will leverage his strategic vision and process expertise to accelerate the company''s misson. The iAssist platform is focused on providing specialty pharmaceutical brands superior capabilities and insights to advance the patient journe ...


08.08.2017

Rising Biosciences, Inc. Initiates Testing for FDA Approval of OTC Chronic Pain Relief Medications

NEW YORK, NY -- (Marketwired) -- 08/02/17 -- Rising India''s (OTC: RSII) ., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry, announces that the Company has entered in the FDA testing phase on its revolutionary medical creams for chronic pain relief and neuropathic pain.These two pain creams will be the first in a series of products. Rising Biosciences, Inc. has retained an indu ...


02.08.2017

NSAV Announces Launch of Heartrescue.net

CRESCO, PA -- (Marketwired) -- 08/01/17 -- NSAV Holding, Inc. (OTC: NSAV) announced today the launch of an upgraded version of China''s premier cardiac emergency response website, . The launch represents yet another major milestone for world renowned Chinese medical software company, Shanghai based Vital Strategic Research Institute (VSRI). VSRI is a medical research firm with a long history of expertise in design, clinical trials and global research. VSRI has collaborated with pharma ...


01.08.2017

Mega Pharma expands rapidly in Latin America

LONDON, ENGLAND -- (Marketwired) -- 07/26/17 -- Over the last decade or so, the pharmaceutical industry has rapidly evolved, coinciding with huge changes to the global economy and the landscape of disease.One of the largest issues organisations now deal with is the world''s rising ageing population. Whereas medicine once dealt with acute disease, it has since moved focus, concentrating instead on chronic afflictions, such as diabetes.Regulations around drug development, however, and t ...


26.07.2017

Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman''s Diagnostics and Treatment Segment

TORONTO, ON -- (Marketwired) -- 07/24/17 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) provides shareholder update on new and existing acquisitions including its medical marijuana venture and progress on its woman''s diagnostics and treatment segment products.Easton has closed on its agreement with Alliance Group and has acquired 45 acres of agriculturally zoned land north of Toronto to cultivate, produce and facilitate the sale of its production of medical marijuana on a co-managed ...


24.07.2017

Rich Pharmaceuticals Announces Collaboration Agreement To Support The Development of Treatments For Parkinson''s Disease

BEVERLY HILLS, CA -- (Marketwired) -- 07/18/17 -- . (OTC PINK: RCHA), a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology, today announced that it has signed a support and collaboration agreement to assist Mega Bridge. Inc., a company which is to be renamed HypGen, Inc., for $100,000 and shares of HypGen common stock."HypGen is commencing work on treatments for Parkinson''s disease. Certain of the data Rich Pharmaceuticals has am ...


18.07.2017

StartCapital and Eight Dragons Company Form Contract on Corporate Development

MIAMI, FL -- (Marketwired) -- 07/14/17 -- (OTCBB: PRTT) is pleased to announce that it has been hired as a consultant to Eight Dragons Company (OTCQB: EDRG) ("Eight Dragons") to provide the following services:(a) StartCapital shall use its best efforts to provide Eight Dragons financial and business consulting services which would include evaluating various business strategies and recommending changes where appropriate and also critically evaluating Eight Dragons'' performan ...


14.07.2017

Abuse-Deterrent Opioid Development and Uptake Are Tied to Efficacy and Regulatory/Payer Policies, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 07/13/17 -- Although 10 new opioid products with abuse-deterrent formulations (ADF) have received regulatory approval in the United States, lack of willingness by insurers to reimburse patients for their use is seen as a primary challenge limiting ADF uptake, according to the .According to Tufts CSDD, 96% of all opioid products prescribed in the U.S. in 2015 lacked abuse-deterrent properties, and only four of the 10 opioid products with abuse-deterrent properties ...


13.07.2017

Skinvisible Improves the Delivery of Cannabis with Patented Invisicare Technology

LAS VEGAS, NV -- (Marketwired) -- 07/07/17 -- Skinvisible Pharmaceuticals, Inc., (OTCQB: SKVI), is a topical and transdermal product development company with a proprietary drug delivery system Invisicare® which improves how ingredients are delivered to and through the skin including the medicinal components of marijuana; specifically CBD (cannabidiol) and the psychoactive marijuana ingredient THC (tetrahydrocannabinol). As part of the Company''s overall growth strategy in this market, ...


07.07.2017

Supreme Receives Sales Approval

TORONTO, ONTARIO -- (Marketwired) -- 06/28/17 -- Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (TSX VENTURE: FIRE) is pleased to announce that its wholly-owned operating subsidiary, 7ACRES, has been granted its permission to sell under the Access to Cannabis for Medical Purposes Regulations.About SupremeSupreme is a Canadian publicly traded company committed to becoming a leading cultivator and distributor of sun grown cannabis through its wholly-owned subsidiar ...


28.06.2017

Fennec Announces Results of Annual Meeting

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 06/28/17 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF) today announced that the nominees listed in the management proxy circular dated May 19, 2017 (the "Circular") for the Annual General and Special Meeting of Shareholders were elected as directors of the Company at the Annual General and Special Meeting of Shareholders held in New York, New York on June 27, 2017. Detailed results of the vote for the election of di ...


28.06.2017

Easton Pharmaceuticals Announces It Has Received $400,000 USD In Product Purchase Orders For The Current Quarter From Its Woman''s Diagnostic And Treatment Products Business For The Mexico Market

TORONTO, ON -- (Marketwired) -- 06/26/17 -- Easton Pharmaceuticals, Inc. (OTC: EAPH), is pleased to announce it has received an approximate total of $400,000 USD in purchase orders for the quarter from its sub-distributors for the Mexican market.The purchase orders include a new order received just last week, including an upfront cash deposit which has brought the total for all Easton / BMV''s woman''s diagnostic and treatment products to approximately $400,000 USD in purcha ...


26.06.2017

Rich Pharmaceuticals Announces Principal Doctor for Clinical Trials

BEVERLY HILLS, CA -- (Marketwired) -- 06/21/17 -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA) ("Rich" or the "Company"), a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology announced today its principal doctor, Dr. Tontanai Numbenjapon, will commence clinical trials in Phramongkutklao Hospital in Thailand.Dr. Numbenjapon specializes in medical oncology, hematology, and stem cell transplantation. He has over 14 years of exper ...


21.06.2017

Supreme Provides License Update

TORONTO, ONTARIO -- (Marketwired) -- 06/19/17 -- Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (TSX VENTURE: FIRE) is pleased to announce that the Company''s wholly-owned subsidiary, 8528934 Canada Ltd. d/b/a 7 Acres ("7ACRES"), received several updates from Health Canada with respect to its cultivation license (the "License") pursuant to the Access to Cannabis for Medical Purposes Regulations ("ACMPR").Update on Sales Appr ...


19.06.2017

Protect Pharmaceuticals Corporation Changes Business Model

MIAMI, FL -- (Marketwired) -- 06/16/17 -- Protect Pharmaceuticals Corporation (OTC: PRTT), a Nevada Corporation, officially announces that it intends to change its name to StartCapital Corporation and modify its business model to a finance company specializing in non equity financing for start-up companies.Protect Pharmaceutical intends to change its name, business model, and stock symbol. Following shareholder approval, the new name will be StartCapital and, in conjunction with the new name, m ...


16.06.2017

Protect Pharmaceuticals Corporation Changes Business Model

MIAMI, FL -- (Marketwired) -- 06/16/17 -- Protect Pharmaceuticals Corporation (OTC: PRTT), a Nevada Corporation, officially announces that it intends to change its name to StartCapital Corporation and modify its business model to a finance company specializing in non equity financing for start-up companies.Protect Pharmaceutical intends to change its name, business model, and stock symbol. Following shareholder approval, the new name will be StartCapital and, in conjunction with the new name, m ...


16.06.2017

VANC Responds to Baseless Letter and Defamatory Comments by Mo Aziz and Canagen

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/15/17 -- Vanc Pharmaceuticals, Inc. ("Vanc") (TSX VENTURE: VANC)(OTCQB: NUVPF) responded today to a demand letter from Canagen Pharmaceuticals Inc. ("Canagen"), in which Canagen claims compensation from Vanc of $510,000. Vanc believes that the claims are wholly without merit, and intends to vigorously defend its position if an action is commenced. Vanc is issuing this news release only because Canagen took the extraordinary ...


15.06.2017

Braeburn Pharmaceuticals and Knight Therapeutics Announce Filing of New Drug Submission for PROBUPHINE(R) in Canada for Opioid Drug Dependence

PRINCETON, NEW JERSEY and MONTREAL, QUEBEC -- (Marketwired) -- 06/13/17 -- Braeburn Pharmaceuticals, Inc. ("Braeburn") and Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, announced today that Knight''s New Drug Submission (NDS) has been accepted for review by Health Canada for PROBUPHINE® (buprenorphine subdermal implant) for the treatment of opioid drug dependence."Probuphine is a unique and innovative pro ...


13.06.2017

Easton Pharmaceuticals Announces It Has Finalized Agreement Terms With Alliance Group For Ownership Stake in Several Businesses On 45 Acres Of Agricultural Land, Which Includes The Cultivation of Medical Marijuana For National Canadian Market

TORONTO, ON -- (Marketwired) -- 06/12/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), is pleased to announce, pursuant to its previously announced Letter of Intent with Canadian based -- Alliance Group -- final Terms have been mutually agreed to on a final agreement to acquire an interest in a 45 acre fully owned parcel of land for the cultivation, production and sale of medical marijuana to the cannabis industry and other revenue generating businesses.Easton will invest up to $1.3 million ...


12.06.2017

Fennec Announces $7.6 Million Private Placement of Common Shares Led by venBio Select Advisor

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 06/08/17 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF) (the "Company" or "Fennec"), a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced chemotherapy ototoxicity in pediatric patients, announced today that it has completed a non-brokered private placement (the "Offering") of 1,900,000 common shares for gross proceeds of U ...


08.06.2017

Rich Pharmaceuticals Announces Institutional Review Board Submission

BEVERLY HILLS, CA -- (Marketwired) -- 06/08/17 -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA) ("Rich" or the "Company"), a biopharmaceutical Company focused on developing and commercializing innovative therapies in oncology announced today that has filed its submission package to the Institutional Review Board (IRB) of Phramongkutklao Hospital in Bangkok, Thailand.The submission is part of a process that leads to a study for the treatment of Acute Myelocytic Leukemia (AML) i ...


08.06.2017

Supreme Announces Listing of Common Shares on the TSX.V under the symbol "FIRE"

TORONTO, ONTARIO -- (Marketwired) -- 06/01/17 -- Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (CSE: SL)(CSE: SL.CN)(CNSX: SL)(OTC PINK: SPRWF) is pleased to announce that it has received final approval from the TSX Venture Exchange ("TSX.V") to list the Company''s common shares on the TSX.V. The common shares are expected to begin trading on the TSX.V at the opening of markets on June 6, 2017 under the symbol "FIRE". In connection ...


01.06.2017

VANC Pharmaceuticals Achieves Listing of 17 Generic Products with National Distributor

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 06/01/17 -- VANC Pharmaceuticals Inc. (TSX VENTURE: VANC)(OTCQB: NUVPF) ("VANC" or the "Company"), a pharmaceutical company focused on the Canadian generic drug and over-the-counter (the "OTC") markets announces today that 11 of the Company''s generic molecules have been listed with the major national distributor and wholesaler of drugs in Canada."I am very pleased to announce that the company has achi ...


01.06.2017

Rich Pharmaceuticals Announces Clinical Site in Thailand

BEVERLY HILLS, CA -- (Marketwired) -- 05/31/17 -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA) ("Rich" or the "Company"), a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology announced today that it has selected a site and obtained investigator''s interest at Phramongkutklao Hospital in Bangkok, Thailand. Rich has engaged CMIC ASIA-PACIFIC, PTE. LTD. ("CMIC") to assist in this project and they have already ...


31.05.2017

Mark Paul appointed President of CROS NT LLC

CHAPEL HILL, NC -- (Marketwired) -- 05/30/17 -- CROS NT announced today that Mark Paul has been appointed President of the company''s North American operations effective June 1, 2017. Paul brings a wealth of operational and commercial experience to the role and most recently has been serving as Senior Vice President of Program Management for CROS NT."Mark is the perfect candidate for what is an important role within the business. He has a strong customer focus and a great underst ...


30.05.2017

Fennec Announces Launch of European Named Patient Programme for Sodium Thiosulfate for Pediatric Patients With Standard Risk Hepatoblastoma

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 05/30/17 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF), a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced ototoxicity in pediatric patients, today announced the launch of a Named Patient Programme (NPP) in Europe for STS. Fennec''s NPP is intended to make STS available to patients before commercial availability in certain countries. Where ...


30.05.2017

UPDATE - CROS NT Announces Extended Partnership With Medidata -- Deploys RaveX

MAIDENHEAD, UNITED KINGDOM and CHAPEL HILL, NC -- (Marketwired) -- 05/24/17 -- CROS NT today announced the go-live of its RaveX team in an extension of the company''s partnership with .Under the partnership, CROS NT will offer its customers -- the latest generation of Medidata''s industry-leading EDC system, Medidata Rave-- as well as Medidata''s randomization and trial supply management (RTSM) system, . The Data Management division in CROS NT offers Sponsors of c ...


24.05.2017

Easton Pharmaceuticals Announces It Has Signed an LOI to Acquire An Interest in a 45 Acre Parcel for the Cultivation of Medical Marijuana in Toronto, Canada; Wholly Owned Subsidiary, iBliss in Birmingham''s UK Vaper Expo

TORONTO, ON -- (Marketwired) -- 05/24/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce that it has signed a Letter of Intent with Canadian Alliance Group to acquire an interest in their 45 acre fully owned parcel of land for the cultivation, production and sale of medical marijuana to the cannabis industry. Easton''s wholly owned subsidiary, iBliss Inc. is currently in Birmingham, UK for this weekend''s Vaper expo.Easton has entered into an LOI agre ...


24.05.2017

Unisys Launches ActiveInsights™ PharmaTrack to Provide Enhanced Visibility and Management of the Entire Pharmaceutical Supply Chain

London, UK., May 23, 2017 – Unisys Corporation (NYSE: UIS) today launched PharmaTrack, new software that combines leading security, advanced data analytics and compliance technology in a single, unified platform to provide life sciences and healthcare companies enhanced visibility and oversight of the entire global pharmaceutical supply chain and thus help combat theft and counterfeit drugs. This newest addition to the Unisys ActiveInsights™ suite of solutions arose from an overlap of industry ...


23.05.2017

CROS NT Announces Extended Partnership With Medidata -- Deploys RaveX

MAIDENHEAD, UNITED KINGDOM and CHAPEL HILL, NC -- (Marketwired) -- 05/23/17 -- CROS NT today announced the go-live of its RaveX team in an extension of the company''s partnership with .Under the partnership, CROS NT will offer its customers -- the latest generation of Medidata''s industry-leading EDC system, Medidata Rave-- as well as Medidata''s randomization and trial supply management (RTSM) system, . The Data Management division in CROS NT offers Sponsors of c ...


23.05.2017

VANC Pharmaceuticals Announces Canadian Distribution Agreement for INSTI® HIV-1/HIV-2 Antibody Test

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/17/17 -- VANC Pharmaceuticals Inc. (TSX VENTURE: VANC)(OTCQB: NUVPD) ("VANC" or the "Company"), a pharmaceutical company focused on the Canadian generic drug and over-the-counter (the "OTC") markets, announces today it has entered into a Canada-wide distribution agreement for INSTI® HIV-1/HIV-2 Antibody Test (INSTI)."We are very pleased to have acquired the Canadian distribution rights to INSTI," comment ...


17.05.2017

Hepatitis C Pipeline Assessment and Therapeutic Landscape Reviewed for H1 2017

Albany, New York, May 19, 2017: Market Research Hub (MRH) has recently highlighted the pipeline landscape of Hepatitis C therapeutics in a new report added to its repository, with a title of “Hepatitis C - Pipeline Review, H1 2017”. The main purpose of this study is to provide an assessment of the various pipeline therapeutics for the disease. For a competitive study, the research has listed key companies functioning in the market, focusing on their research and development efforts, adoption to ...


19.05.2017

Fennec Provides Corporate Update and Announces First Quarter 2017 Results

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 05/12/17 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF), a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced ototoxicity in pediatric patients, today reported its corporate update and financial results for the first quarter ended March 31, 2017.Upcoming Events for 2017Investor Events:Corporate Milestones:"Our highest priority remains the preparat ...


12.05.2017

Accelerating Pace of Approvals and a Strong Development Pipeline Indicate Vigorous Growth for New Biotech Products, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 05/09/17 -- Biopharmaceuticals accounted for 35% of all new drug approvals in the United States from 2006 through 2016, and a robust development pipeline suggests that the recent increased pace of biotech approvals will continue for the next decade, according to a newly completed assessment from the .The annual pace of 13 new biotech products approvals by the U.S. Food and Drug Administration during the study period accelerated to more than 20 per year during 2014 ...


09.05.2017

Current Trends in Global Animal Pharmaceutical Industry Examined in Latest Forecast Report 2017

Albany, New York, May 08, 2017: The trend of adopting pets is increasing globally, which is supporting the growth of the global animal healthcare and pharmaceutical market to some extent. A new study, focusing on the booming trends that are boosting the industry of animal pharmaceutical, has been added to the wide portfolio of Market Research Hub (MRH), and titled as “Global Animal Pharmaceutical Industry 2017, Trends and Forecast Report”. It includes an executive summary along with a market ove ...


08.05.2017

Supreme Updates Board of Directors and Provides Licensing Update

TORONTO, ONTARIO -- (Marketwired) -- 05/08/17 -- Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (CSE: SL)(CSE: SL.CN)(CNSX: SL) is pleased to announce that Mr. Ron Factor, B.A.Sc, MBA, has joined its Board of Directors. Mr. Factor was the founder of the global supply chain management consulting practice at Deloitte Consulting in Toronto. He will replace Mr. Chuck Rifici on the Board, who has resigned to focus his efforts on a new venture. The Supreme Board of Dir ...


08.05.2017

Fatty Liver Disease Market Covering In-Depth Analysis of Diseases, Targets & Therapies, Growth Driven by Premium Innovation

Albany, New York, 04 May 2017: According to the current health sector trends, the fatty liver disease market is booming due to the rise in lifestyle related disorders. Market Research Hub (MRH) has included the new study to its vast repository of research studies which is titled as, ‘‘Frontier Pharma : Fatty Liver Disease - High Degree of First-in-Class Innovation, Dominated by Nuclear Receptor-Targeting NASH Products’’. The report reveals the newest research, innovations and business possibilit ...


05.05.2017

Pharmaceutical Lifecycle Management Sector Driven by High Growth Rate, Trends & Market Analysis Highlighted till 2017

Albany, New York, May 05, 2017: Each year businesses see a greater percentage of pharmaceutical lifecycle management strategies being used. This sector is significantly creating revenue for many pharmaceutical giants. A fresh study has been added to the vast repository of the Marketing Research Hub (MRH), which is titled ‘‘Pharmaceutical Lifecycle Management Strategies in 2017’’. This synopsis concentrates on the engaging analysis of the LCM or life management strategies sectors market growth, t ...


05.05.2017

Easton Pharmaceuticals Announces Signing LOI For The Acquisition Of Revenue Producing, Israel Based Therapeutics Company, Herbs Of Kedem

TORONTO, ON -- (Marketwired) -- 05/02/17 -- Easton Pharmaceuticals, Inc. (OTC: EAPH) announces it has signed an LOI for the acquisition of revenue producing, Israel based therapeutics company, Herbs of Kedem.Herbs of Kedem is an Israeli based company with sales in excess of $2,200,000 US and healthy profit margins with a current net profit of approximately $1,500,000 US with minimal marketing exposure. Herbs of Kedem currently has a total of 10 adult skin care and anti-aging products, 5 hair ca ...


02.05.2017

Rising Biosciences, Inc. Launches Corporate Website, Announces Executive Research Team

NEW YORK, NY -- (Marketwired) -- 04/27/17 -- Rising India Inc. (OTC: RSII) is pleased to announce that Rising Biosciences, Inc., The Company''s recently finalized merger entity, has officially launched its corporate website, detailing its mission statement, corporate objectives and newly appointed research executives.Rising Biosciences, Inc. is a research & development company focusing on oral and topical cannabis and non-cannabis based pharmaceuticals with strict standards set f ...


27.04.2017

Fennec to Present at Pioneers 2017 Joseph Gunnar Conference on May 2, 2017 in New York City

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 04/27/17 -- Fennec Pharmaceuticals, Inc. (TSX: FRX)(OTCQB: FENCF), today announced that Rosty Raykov, CEO of Fennec, will be presenting at the PIONEERS 2017 Joseph Gunnar Conference on Tuesday, May 2 at 2:00 PM ET in the South Salon II at the Mandarin Oriental Hotel in New York City. Management will also be available to meet with investors during the conference.The Fennec presentation slides can be accessed by visiting the investor sec ...


27.04.2017

Eight Dragons Announces the Appointment of Martin Schmieg as Chief Financial Officer

MIAMI, FL -- (Marketwired) -- 04/26/17 -- Eight Dragons Co. (OTC: EDRG) announced today the appointment of Martin Schmieg as Chief Financial Officer. Mr. Schmieg will be responsible for the management and oversight of Eight Dragons'' financial analysis, planning and reporting."We are pleased to welcome Martin to Eight Dragons," said Una Taylor, Chairman and CEO of Eight Dragons. "His experience and expertise in finance at the senior-most levels are critical to ensuring ...


26.04.2017

Global Big Pharma Partnering Terms and Agreements Rising by Demand for Better Health Care, Critical Deals during 2010-2017

Albany, New York, April 26, 2017: In the current times, growing population and demands for better health care has enabled big pharma partnering deals. To analyze this health care related sector in precision, a fresh report has been included in the vast repository of Market Research Hub (MRH), with the title “Global Big Pharma Partnering Terms and Agreements 2010-2017: Deal trends, players, and financials’’. The study will certainly enrich pharma businesses by covering the current situation and t ...


26.04.2017

Easton Pharmaceuticals Announces Signing NDA and Starts Negotiations For Acquisition

TORONTO, ON -- (Marketwired) -- 04/24/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce that it has signed a non-disclosure / confidentiality agreement with a Producer of Crop Protection, Fertilizer and Plant Wash Products Company based in Israel.Easton has signed non-disclosure agreement and has started negotiations with a high level meeting planned with the Israeli based company this week to discuss possible acquisition / joint venture / distribution agreements betwee ...


24.04.2017

VANC Pharmaceuticals Appointment of Mr. Alan Arnstein to its Board of Directors

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 04/20/17 -- VANC Pharmaceuticals Inc. (TSX VENTURE: VANC)(OTCQB: NUVPD) ("VANC" or the "Company"), a pharmaceutical company focused on the Canadian generic drug and over-the-counter (the "OTC") markets is pleased to announce the appointment of Mr. Alan Arnstein to VANC''s Board of Directors."We are delighted to have Mr. Arnstein join our company and believe it is a vote of confidence on our long term s ...


20.04.2017

Easton Pharmaceuticals Announces Signing Of Purchase Agreement Completing The Acquisition Of Revenue Producing Vaporizer and e-Liquids Manufacturer iBliss, Inc.

TORONTO, ON -- (Marketwired) -- 04/20/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce the execution of final agreement completing the 100% acquisition of revenue generating vaporizer and e-liquids manufacturer, iBliss Inc. and its holding company.Easton Pharmaceuticals and iBliss, Inc. executed the closing final agreement, officially concluding the 100% acquisition of iBliss from its holding company. Terms of the acquisition included installment cash payments to be pa ...


20.04.2017

Bradmer Announces Fourth Quarter and Full Year 2016 Financial Results

TORONTO, ONTARIO -- (Marketwired) -- 04/18/17 -- Bradmer Pharmaceuticals Inc. (NEX: BMR.H) ("Bradmer" or the "Company") today announced its fourth quarter and full year 2016 financial results.Financial ResultsAmounts in US dollars, unless specified otherwise, and results prepared in accordance with International Financial Reporting Standards ("IFRS").For the three months ended December 31, 2016, the Company recorded a net loss of $21,000 or $0.001 per common share ...


18.04.2017

Proto Script Pharmaceutical Signs Medical Equipment Supply Agreement with PAKmed

RANCHO CUCAMONGA, CA -- (Marketwired) -- 04/18/17 -- Proto Script Pharmaceutical Corp. dba PSP Homecare ("PSP" or the "Company") (OTC PINK: PSCR), a durable medical equipment provider, is pleased to announce that the Company has entered into a Supply Agreement with PAKmed LLC ("PAKmed"), a manufacturer of premium orthotic braces based in Louisville, Kentucky.Under terms of the Supply Agreement, PAKmed will provide PSP certain premium orthotic braces for shipment to ...


18.04.2017

Reading Health System Continues to Align and Engage Its Physician Leaders by Expanding the Reach of the Applied Physician Leadership Academy(C)

NEW YORK, NY -- (Marketwired) -- 04/18/17 -- Reading Health System, in conjunction with The Leadership Development Group, is changing its culture by focusing on physician leadership, alignment, and engagement. This month twenty-eight of the top ranked physician leaders from Reading Health System (RHS) graduated from The Leadership Development Group''s Applied Physician Leadership Academy (APLA©), an 18-month customized leadership development program, designed to engage and develop phy ...


18.04.2017

Groupe Athena, Inc. Posts Strong 3rd Quarter Results

MUMBAI, INDIA -- (Marketwired) -- 04/11/17 -- Groupe Athena, Inc. (OTC: GATA) announced today revenues of $10,665,210 for the period ending March 31, 2016. Operating income before depreciation, amortization and taxes were $1,662,277 while net income was $1,233,147.Total revenues for the 9 month period this fiscal year were $43,816,222 which is well on pace to meet the previously announced 12 month guidance. Cash reserves in the form of short term investments and deposits are extremely healthy w ...


11.04.2017

Easton Pharmaceuticals Announces Finalization Of Agreement For The Acquisition Of Major Vaporizer and e-Liquids Manufacturer iBliss Inc; Annual Sales Projected To Once Again Reach $15,000,000 With Healthy Profit Margins in Excess of 40%

TORONTO, ON -- (Marketwired) -- 04/11/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) announces it has finalized all terms of the Acquisition Agreement to acquire revenue producing vaporizer, e-liquids manufacturer iBliss Inc., of Toronto, Ontario, whereas legal counsel will be quickly concluding the closing of the transaction.After various delays and much negotiation, Easton Pharmaceuticals is pleased to announce that both Easton and iBliss have agreed to and finalized all terms of the Acq ...


11.04.2017

Supreme Announces Conditional Approval to List on the TSX.V

TORONTO, ONTARIO -- (Marketwired) -- 04/10/17 -- Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (CSE: SL)(CSE: SL.CN) is pleased to announce that it has received conditional approval from the TSX Venture Exchange ("TSX.V") to list the Company''s common shares on the TSX.V.John Fowler, President and CEO, stated: "Graduating from the CSE to the TSX.V is an important milestone for Supreme. We enjoyed tremendous success throughout our time on ...


10.04.2017

BioStem Technologies Inc. (OTC PINK: BSEM) Announces Audit Process and Uplisting Plans to the OTCQX Market

OAKLAND PARK, FL -- (Marketwired) -- 04/06/17 -- BioStem Technologies Inc. (OTC PINK: BSEM) ("BioStem Tech" or the "Company"), an emerging International Biotechnology company, engaged D. Brooks and Associates CPA''s, P.A. as their PCAOB registered certified public auditing firm.As BSEM transitions out of the start-up phase and into the growth stage, the corporate team will be shifting focus to driving future revenues from its pharmaceutical divisions starting this ...


06.04.2017

March and Exhibition Exposes 300 Years of Psychiatric Abuse in Italy and the US

Hundreds are protesting a European Psychiatric Association (EPA) Congress being held in Florence on April 1, saying the conference promotes dangerous psychotropic (mind-altering drugs) and brain-damaging interventions that puts Italians and other Europeans mental health and lives at risk. In support of this demonstration, the [Citizens Commission of Human Rights of Florida](http://www.cchrflorida.org/) is calling upon all members in the state and across the country to make their voices heard by ...


01.04.2017

Rising India Inc. Executes Definitive Merger Agreement with Rising BioSciences, Inc.

NEW YORK, NY -- (Marketwired) -- 03/30/17 -- Rising India Inc. (OTC: RSII) announces today that it has executed the definitive merger agreement with Rising BioSciences, Inc. Appointments of new management and directors, as well as additional details on company objectives and plans will be forthcoming in future announcements.Rising BioSciences, Inc. is a research and development company focusing on oral and topical cannabis based pharmaceuticals with strict standards set forward by the pharmaceu ...


30.03.2017

Fennec Provides Corporate Update and Announces Fiscal Year Ended December 31, 2016 Financial Results

RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 03/30/17 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF), a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced ototoxicity in pediatric patients, today reported its corporate update and financial results for the year ended December 31, 2016."We are pleased with the progress made throughout 2016 including our $5.0 million equity financing and additi ...


30.03.2017

BioStem Technologies, Inc. Announces Issuance of Prescription Drug Repackager Permit for Qualified Pharma Ingredients Inc.

POMPANO BEACH, FL -- (Marketwired) -- 03/27/17 -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BSEM" or "the company"), an emerging International Biotechnology company, is eager to announce that its Oakland Park, Florida-based subsidiary, Qualified Pharma Ingredients Inc. ("QPI"), has been granted their Prescription Drug Repackager permit from the Florida Department of Business & Professional Regulation.This license will allow QPI to supply superior qualified ...


27.03.2017

VANC Pharmaceuticals Provides Marketing Update

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 03/24/17 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: VANC)(OTCQB: NUVPD), a pharmaceutical company focused on the Canadian generic drug and over-the-counter (the "OTC") markets provides marketing update as part of its ongoing program to bring value added products to the Canadian pharmacy industry."I am pleased to announce that VANC''s premium natural iron supplement Hema-Fer™ h ...


24.03.2017

Easton Pharmaceuticals Announces Advancing $300,000 Payment To CommonSense Ltd. Paving The Way For The Anticipated Closing Of Exclusive Sub-Distribution Agreement For Product AL-Sense with 2nd Quarter Launch

TORONTO, ON -- (Marketwired) -- 03/22/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) announces it has forwarded together with BMV Medica a $300,000 payment to CommonSense of Israel clearing the way for the closing of an anticipated exclusive sub-distribution agreement with a major, multi-national, pharmaceutical company for the women''s diagnostic product AL-Sense (AmnioSense). In addition, Easton / BMV through their commercial alliance partner Ackerman Pharma, provides update on ...


22.03.2017

Rich Pharmaceuticals to Launch CannCodex, marking its entry into Medicinal Cannabis Industry

BEVERLY HILLS, CA -- (Marketwired) -- 03/21/17 -- Rich Pharmaceuticals, Inc. (OTC PINK: RCHA) ("Rich" or the "Company"), a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology, announced today that it has reached agreement with I Tech Health Corp. to form a subsidiary and launch CannCodex to serve the Medicinal Cannabis industry as well as provide data and services to pharmaceutical companies worldwide.The strategic move was id ...


21.03.2017

Easton Pharmaceuticals Provides Update On Its Previous Investment Into AMFIL Technologies and Their Recent Revenue Producing Acquisitions & The GROzone Technology For The Medical Marijuana Industry; Initiates Negotiations For Proposed Investment

TORONTO, ON -- (Marketwired) -- 03/15/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) Provides update on its previous investment into AMFIL Technologies and their recent revenue generating business acquisitions and their AMFIL GROzone technology for the medical marijuana industry (OTC PINK: AMFE).Easton Pharmaceuticals in 2014 completed an investment into AMFIL Technologies with an option to purchase additional equity. The investment was originally used to assist AMFIL in general expenses a ...


15.03.2017

Supreme Announces License Update

TORONTO, ONTARIO -- (Marketwired) -- 03/10/17 -- Supreme Pharmaceuticals Inc. ("Supreme" or the "Company") (CSE: SL)(CSE: SL.CN) announces that its wholly-owned subsidiary 7 ACRES has received a renewal of its license to cultivate cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations ("ACMPR"). Supreme also understands that Health Canada is in the final phase of its review of 7 ACRES'' application (the "Application") for ...


10.03.2017

Streamlined Development Process for Certain New Drug Applications Is Not Facilitating Shorter Approval Times, According to the Tufts Center for the Study of Drug Development

BOSTON, MA -- (Marketwired) -- 03/08/17 -- The 505(b)(2) approval pathway for new drug applications in the United States, aimed at avoiding unnecessary duplication of studies performed on a previously approved drug, has not led to shorter approval times, according to a recently completed analysis conducted by the ."While the 505(b)(2) regulatory pathway has been highly successful in bringing new therapies to market from 2009 through 2015, drug products approved under this pathway had a lon ...


08.03.2017

Easton Pharmaceuticals Provides Update On Acquiring Major Vaporizer and e-Liquids Manufacturer iBliss, Inc.

TORONTO, ON -- (Marketwired) -- 03/08/17 -- Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) provides an update on its acquisition of revenue producing vaporizer, e-liquids manufacturer and medical marijuana company, iBliss Inc., of Toronto, Ontario, Canada.Since the previously announced letter of intent to acquire revenue generating vaporizer manufacturer and medical marijuana company iBliss Inc., both parties have engaged in detailed negotiations to reach terms on a final closing agreement. Nego ...


08.03.2017

Rising India Inc. Moves Forward With Final Agreement on Rising BioSciences Merger

NEW YORK, NY -- (Marketwired) -- 03/06/17 -- Rising India Inc. (OTC: RSII) is pleased to announce that they are preparing to execute final documents for the incoming merger of Rising BioSciences, Inc., a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry.CEO Jim DiPrima feels this will be an incredible opportunity for the company and its shareholders moving forward. DiPrima has agreed to step ...


06.03.2017

Easton Pharmaceuticals Announces The Closing Of A Financing Facility With Additional Financing Commitments; Provides Other Updates

TORONTO, ON -- (Marketwired) -- 03/03/17 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) Announces it has closed on an interim financing with additional financing funds committedEaston Pharmaceuticals has closed on an interim financing facility up to $2,000,000, of which it has been provided access to. This facility also provides for an additional commitment of funds depending upon the company''s requirements. Terms of the facility are in the form of a loan, convertible to restricted ...


03.03.2017

Sermonix Pharmaceuticals Secures Worldwide Rights to Oral Lasofoxifene From Ligand Pharmaceuticals, Expanding From U.S., Japan

COLUMBUS, OH -- (Marketwired) -- 02/28/17 -- Sermonix Pharmaceuticals LLC, a privately held biotechnology company focused on the development and commercialization of female-specific oncology products, today announced it licensed worldwide rights to develop and commercialize oral lasofoxifene, its lead investigational drug, from Ligand Pharmaceuticals Inc. (NASDAQ: LGND). Sermonix initially licensed oral lasofoxifene rights from Ligand in February 2015, covering the U.S., Japan and other select ...


28.02.2017

Rising India Inc. Highlights Shareholder Conference Call Regarding Cannabis Pharmaceutical Research and Development Merger

NEW YORK, NY -- (Marketwired) -- 02/27/17 -- Rising India Inc. (OTC: RSII) has received several requests from shareholders for a recap to the Company''s Shareholder Conference call which featured detailed information about the incoming merger company, Rising Biosciences, Inc.Rising BioSciences, Inc. will be a research and development company focusing on oral and topical pharmaceuticals with strict standards set forward by the pharmaceutical compounding industry. Aside from cancer trea ...


27.02.2017

VANC Pharmaceuticals Launches New OTC Laxative Product Sennace

VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 02/27/17 -- VANC Pharmaceuticals Inc. ("VANC" or the "Company") (TSX VENTURE: VANC)(OTCQB: NUVPD), a pharmaceutical company focused on the Canadian generic drug and over-the-counter (the "OTC") markets announces the launch of a new OTC laxative to the market place. Sennace represents another in a series of OTC products launched and to be launched by VANC."We are very excited about our new laxative offering," ...


27.02.2017

Global Antibacterial Drugs Market to 2022 Vaccines Retain Market Industry Report

Albany, New York, February 15, 2017: Market Research Hub has recently announced the addition of a new report to it broad database titled as “Global Antibacterial Drugs Market to 2022 - Vaccines Retain Market Prominence While Pipeline Offers Innovative Approaches to Tackling Antimicrobial Resistance”. This report considers the key developments in this market, with particular focus on drugs indicated for use in pneumonia, methicillin-resistant staphylococcus aureus (MRSA), sepsis and tuberculosis. ...


15.02.2017

RespireRx Pharmaceuticals Inc. to Present at BIO CEO & Investor Conference 2017

GLEN ROCK, NJ -- (Marketwired) -- 02/10/17 -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) ("RespireRx" or the "Company"), a leader in the development of medicines for the treatment of respiratory disorders for which there are no approved pharmaceuticals, particularly sleep apneas and respiratory depression resulting from pain management medicines and disabilities such as spinal cord injury, announces that the Company''s President, Chief Executive Officer and Vice ...


10.02.2017



All members: 9 429
Register today: 0
Register yesterday: 1
Members online: 0
Guests online: 110


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.